Berlin, Germany

Markus Hammer

This inventor holds 1 USPTO granted patent. Top assignee: Charité – Universitätsmedizin Berlin. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markus Hammer. Retrieved from https://idiyas.com/inventor/markus-hammer-hkt37662

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Markus Hammer in the Field of Medicine

Introduction

Markus Hammer is a notable inventor based in Berlin, Germany. He has made significant contributions to the medical field, particularly in the treatment of viral infections. His work focuses on innovative approaches that leverage advanced scientific understanding to improve patient outcomes.

Latest Patents

Markus Hammer holds a patent for the "Use of a B-cell-depleting antibody for treatment of polyoma virus infections." This invention relates to the application of a B-cell-depleting antibody specifically designed to treat infections caused by the polyoma virus. His innovative approach has the potential to enhance therapeutic options for patients suffering from this viral infection.

Career Highlights

Markus Hammer is affiliated with Charité-Universitätsmedizin Berlin, a prestigious medical institution known for its research and clinical excellence. His role at this institution allows him to collaborate with leading experts in the field and contribute to groundbreaking research initiatives.

Collaborations

Throughout his career, Markus has worked alongside esteemed colleagues such as Petra Reinke and Hans-Dieter Volk. These collaborations have fostered a rich environment for innovation and have led to advancements in medical research and treatment methodologies.

Conclusion

Markus Hammer's contributions to the field of medicine, particularly through his patent on B-cell-depleting antibodies, highlight his commitment to advancing healthcare solutions. His work exemplifies the impact of innovative thinking in addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…